Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.
Amalgam Rx has raised $7.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.
Amalgam Rx's investors include Catalio Capital Management, Novo Nordisk, Mentors Fund, CVS Health Ventures, Supermorpheus.
Amalgam Rx is headquartered in Wilmington, United States.
Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.
Amalgam Rx is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amalgam Rx — Funding & Investors." VCBacked, August 15, 2025, https://www.vcbacked.co/company/amalgam-rx. Accessed August 15, 2026.
VCBacked. (2025). Amalgam Rx — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/amalgam-rx
{{cite web |title=Amalgam Rx — Funding & Investors |url=https://www.vcbacked.co/company/amalgam-rx |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated